Literature DB >> 12890175

Protective effect of coadministered superoxide dismutase and catalase against stress-induced gastric mucosal lesions.

Yoshiji Ohta1, Keiji Nishida.   

Abstract

1. There are conflicting reports as to the protective effect of coadministered native superoxide dismutase (SOD) and catalase against gastric mucosal lesions in rats with water immersion restraint (WIR) stress. It is unclear how coadministered native SOD and catalase protect against WIR stress-induced gastric mucosal lesions. Therefore, in the present study, we re-examined the protective effect of coadministered native SOD and catalase against gastric mucosal lesions in rats with WIR stress. 2. Gastric mucosal lesions were induced in Wistar rats by 3 h WIR. Rats were injected subcutaneously with a mixture of purified bovine erythrocyte SOD and bovine liver catalase 1 h before the onset of WIR. Ulcer index, serum SOD, catalase and xanthine oxidase (XO), uric acid and gastric mucosal SOD, catalase, XO, myeloperoxidase (MPO; an index of tissue neutrophil infiltration), non-protein sulfhydryl (NP-SH) and thiobarbituric acid-reactive substances (TBARS; an index of lipid peroxidation) were assayed in all rats used. 3. Rats with 3 h WIR showed gastric mucosal lesions. Pre-administration of SOD plus catalase to rats with WIR prevented lesion formation. In the serum of rats with WIR alone, XO activity and uric acid concentration increased, whereas SOD and catalase activities did not change. Pre-administration of SOD plus catalase to rats with WIR did not affect increased serum XO activity and uric acid concentration, but did increase serum SOD and catalase activities. In the gastric mucosa of rats with WIR alone, increases in MPO activity and TBARS concentration and a decrease in NP-SH concentration occurred, whereas XO, SOD and catalase activities did not change. Pre-administration of SOD plus catalase to rats with WIR attenuated the changes in gastric mucosal MPO activity and TBARS and NP-SH concentrations, but did not affect gastric mucosal XO, SOD and catalase activities. Pre-administration of SOD plus catalase (in an inactivated form) to rats with WIR had no effect on gastric mucosal lesion formation and the levels of serum and gastric mucosal parameters studied. 4. These results indicate that coadministered native SOD and catalase protect against gastric mucosal lesions in rats with WIR stress and suggest that this protective effect of coadministered native SOD and catalase could be due to their activity to scavenge XO-derived active oxygen species that are increased in the blood.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890175     DOI: 10.1046/j.1440-1681.2003.03871.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  5 in total

1.  Effects of Bidens pilosa L. var. radiata Scherff on experimental gastric lesion.

Authors:  Masako Horiuchi; Hiroshi Wachi; Yoshiyuki Seyama
Journal:  J Nat Med       Date:  2010-06-05       Impact factor: 2.343

2.  Role of gastric mucosal ascorbic acid in gastric mucosal lesion development in rats with water immersion restraint stress.

Authors:  Yoshiji Ohta; Yoshio Kamiya; Yoichiro Imai; Tomiyasu Arisawa; Hiroshi Nakano
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 3.  Concepts of oxidative stress and antioxidant defense in Crohn's disease.

Authors:  Mohammed A Alzoghaibi
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

4.  Effects of Ginkgo biloba extract on cytoprotective factors in rats with duodenal ulcer.

Authors:  Jane C J Chao; Huei-Chen Hung; Sheng-Hsuan Chen; Chia-Lang Fang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

5.  Comparative proteomic analysis of rats subjected to water immersion and restraint stress as an insight into gastric ulcers.

Authors:  Zheng-Rong Zhou; Pan Huang; Guang-Hao Song; Zhuang Zhang; Ke An; Han-Wen Lu; Xiao-Li Ju; Wei Ding
Journal:  Mol Med Rep       Date:  2017-08-14       Impact factor: 2.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.